Diabetes Mellitus Type 2 - Insulin-Treated Clinical Trial
Official title:
Evaluation of the Efficacy and Safety of ToleraCell (Apoptotic Donor Leukocytes) and Induction Immunosuppression With Anti-CD40 Monoclonal Antibody DFI105, Sirolimus, Etanercept, and Tocilizumab for Induction of Tolerance to Islet Allotransplants in Subjects With Predominantly β-Cell Failure-mediated Type 2 Diabetes
The goal of this phase 1, first-in-human, interventional study is to test if the therapy can allow for successful islet transplantation from an unrelated donor without the use of long-term immunosuppression (or induce tolerance to islets). The study will examine results of six islet transplants performed in patients with a specific form of insulin-dependent type 2 diabetes. The main questions it aims to answer are: - Is the tolerance inducing therapy safe; and - Can the tolerance inducing therapy allow for the transplanted islets to survive and produce insulin without the use of the long-term immunosuppression commonly used after islet transplant. Participants will be asked to undergo islet transplant and repeat metabolic testing (requires hospitalization), track their blood glucose with a study provided continuous glucose monitor, and self-administer some of the therapy drugs. Over 75 days, treatments given in addition to standard of care for islet transplant (only if a suitable transplant donor is identified) are: An experimental cell therapy made from the donor's spleen (ToleraCell) An experimental antibody (DFI-105) Three other drugs that have been previously used in islet transplantation (sirolimus, etanercept, tocilizumab) Researchers will track your blood glucose, metabolic status, and insulin use over one year post-transplant and follow your overall health status for 5 years.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05409391 -
Insulin Titration System Based on Deep Learning
|
N/A | |
| Terminated |
NCT04678661 -
My Dose Coach Mobile App to Support Insulin Titration and Maintenance
|
N/A | |
| Completed |
NCT05369871 -
Evaluation of a Closed-loop System for the Treatment of Type 2 Diabetes at Home (DT2_2)
|
N/A | |
| Completed |
NCT05806190 -
Hypoglycaemia (Low Blood Sugar) in Adults With Diabetes and Adrenal Failure
|